U.S, November 27, 2019 (HEMPGAZETTE) A recent study out of Washington State University indicates inhaled cannabis may reduce the intensity of headaches and migraines.
Led by Carrie Cuttler, a WSU assistant professor of psychology, a research term analyzed information submitted by more than 1,300 patients who used the Strainprint app...
U.S, February 5, 2020 (HEMPHAZETTE) (South Carolina Department of Agriculture (SCDA) announced on Friday it was to begin accepting hemp cultivation, handling and processing applications from February 1.
For the 2020 growing season, there won’t be any caps on the number of permits that...
CANADA, February 4, 2020 (HEMPINDUSTRY) Editor’s note: This is part of an occasional series on retailing trends in the hemp industry.
Canada’s federal health regulator is reviewing the potential market for cannabis health products that would not require physician oversight, a review that...
U.S, July 9 2021 (ANALYTICALCANNABIS) It’s long been known that cannabis can impair a consumer’s memory and their ability to recall information.
But in a new study, a group of researchers have found that, contrary to their predictions, high potency cannabis concentrates don’t seem to significantly...
U.S, January 19, 2020 (OPENACCESSNEWS) Michael Jacobs, marketing and creative content specialist at GotVape.com offers his insight into how medical marijuana has the potential to help people lose weight.
Using marijuana and losing weight might seem like a contradiction. One of its most well-known effects...
UNITED KINGDOM, October 9, 2019, (HEALTH EUROPA) - Zelda Therapeutics Limited has announced a proposed merger of equals with Ilera Therapeutics LLC (Ilera Therapeutics).
Ilera Therapeutics is a privately held medical cannabis and cannabinoid science company based in the United States and, subject to approval from Zelda shareholders and all conditions of sale being met,...





